SI0731099T1 - N-(3-benzofuranyl)urea-derivatives - Google Patents

N-(3-benzofuranyl)urea-derivatives

Info

Publication number
SI0731099T1
SI0731099T1 SI9630186T SI9630186T SI0731099T1 SI 0731099 T1 SI0731099 T1 SI 0731099T1 SI 9630186 T SI9630186 T SI 9630186T SI 9630186 T SI9630186 T SI 9630186T SI 0731099 T1 SI0731099 T1 SI 0731099T1
Authority
SI
Slovenia
Prior art keywords
benzofuranyl
urea
derivatives
Prior art date
Application number
SI9630186T
Other languages
English (en)
Slovenian (sl)
Inventor
Gabriele Dr. Br�unlich
R�diger Dr. Fischer
Mazen Dr. Es-Sayed
Rolf Dr. Henning
Michael Dr. Sperzel
Karl-Heinz Dr. Schlemmer
Ulrich Dr. Nielsch
Stephen Dr. Tudhope
Graham Dr. Sturton
Trevor S. Dr. Abram
Mary F. Fitzgerald
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SI0731099T1 publication Critical patent/SI0731099T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)
SI9630186T 1995-03-06 1996-02-22 N-(3-benzofuranyl)urea-derivatives SI0731099T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives
EP96102650A EP0731099B1 (de) 1995-03-06 1996-02-22 N-(3-Benzofuranyl)Harnstoffderivate

Publications (1)

Publication Number Publication Date
SI0731099T1 true SI0731099T1 (en) 2000-08-31

Family

ID=10770709

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630186T SI0731099T1 (en) 1995-03-06 1996-02-22 N-(3-benzofuranyl)urea-derivatives

Country Status (42)

Country Link
US (2) US6399657B1 (de)
EP (1) EP0731099B1 (de)
JP (1) JP3204901B2 (de)
KR (2) KR100405579B1 (de)
CN (2) CN1134419A (de)
AR (1) AR002710A1 (de)
AT (1) ATE193704T1 (de)
BG (2) BG100396A (de)
BR (1) BR9600930A (de)
CA (1) CA2170824A1 (de)
CO (1) CO4370145A1 (de)
CZ (1) CZ66796A3 (de)
DE (1) DE69608721T2 (de)
DK (1) DK0731099T3 (de)
DZ (1) DZ1998A1 (de)
EE (1) EE03921B1 (de)
ES (1) ES2147320T3 (de)
FI (1) FI960998A (de)
GB (1) GB9504460D0 (de)
GR (1) GR3034240T3 (de)
HK (1) HK1013285A1 (de)
HR (1) HRP960071B1 (de)
HU (1) HU222282B1 (de)
IL (1) IL117349A (de)
MA (1) MA23815A1 (de)
MY (1) MY117526A (de)
NO (1) NO313672B1 (de)
NZ (1) NZ286107A (de)
PE (1) PE43597A1 (de)
PL (1) PL189206B1 (de)
PT (1) PT731099E (de)
RO (1) RO116622B1 (de)
RU (1) RU2162845C2 (de)
SI (1) SI0731099T1 (de)
SK (1) SK281817B6 (de)
SV (1) SV1996000015A (de)
TN (1) TNSN96035A1 (de)
TR (1) TR199600177A2 (de)
TW (1) TW336934B (de)
UA (1) UA46714C2 (de)
YU (1) YU49359B (de)
ZA (1) ZA961774B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) * 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
EP1129068A1 (de) * 1998-11-12 2001-09-05 Ariad Pharmaceuticals, Inc. Bizyclische inhibitoren von signal-transduktion, sie enthaltende zusammensetzungen und ihre verwendungen
GB2350109A (en) 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
HUP0600156A2 (en) * 2002-02-22 2006-06-28 Bayer Pharmaceuticals Corp Benzofuran and benzothiophene deruvatives useful in the treatment of hyper-proliferative disorders
AU2003295605A1 (en) 2002-11-19 2004-06-15 Achillion Pharmaceuticals, Inc. Substituted aryl thioureas and releated compounds; inhibitors of viral replication
AU2003303678A1 (en) 2003-01-03 2004-08-10 Genzyme Corporation Urea derivatives and their use as anti-inflammatory agents
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (ja) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. 新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
UA101556C2 (uk) 2006-07-05 2013-04-10 Нікомед Гмбх Комбіноване застосування інгібітора pde 4 та інгібітора hmg-coa-редуктази для профілактики або зцілювального лікування запального захворювання легенів
WO2012123353A1 (en) 2011-03-17 2012-09-20 Algiax Pharmaceuticals Gmbh Novel use of benzofuranylsulfonates
WO2013156232A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of benzofuranylsulfonates in neuropathic pain
AU2015233686B2 (en) 2014-03-18 2019-07-11 Algiax Pharmaceuticals Gmbh 2-Cyano-3-cyclopropyl-3-hydroxy-N-aryl-thioacrylamide derivatives
EP3165224A1 (de) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Verwendung von pde4 hemmern zur prophylaxe und/oder therapie von dyslipoproteinaemie und verwandten erkrankungen
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (de) 2020-12-22 2022-06-29 Paul Scherrer Institut Verfahren zur herstellung einer fächerförmigen optik mit hohem aspektverhältnis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559687B2 (en) * 1981-07-01 1987-03-19 Upjohn Company, The Pyridinyl-and imidazolyl-benzofurane and benzothiophenes
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
EP0146243A1 (de) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase-Inhibitoren
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
CZ66796A3 (en) 1996-09-11
RU2162845C2 (ru) 2001-02-10
NZ286107A (en) 1998-08-26
US6677372B2 (en) 2004-01-13
BG100396A (bg) 1996-12-31
CN1134419A (zh) 1996-10-30
MY117526A (en) 2004-07-31
SV1996000015A (es) 1997-02-17
HU9600549D0 (en) 1996-04-29
EE03921B1 (et) 2002-12-16
NO960884L (no) 1996-09-09
AR002710A1 (es) 1998-04-29
BG62732B1 (bg) 2000-06-30
ATE193704T1 (de) 2000-06-15
TW336934B (en) 1998-07-21
HRP960071B1 (en) 2001-04-30
YU49359B (sh) 2005-09-19
TNSN96035A1 (fr) 2005-03-15
TR199600177A2 (tr) 1996-10-21
DK0731099T3 (da) 2000-09-25
AU705667B2 (en) 1999-05-27
US6399657B1 (en) 2002-06-04
GB9504460D0 (en) 1995-04-26
JPH08253466A (ja) 1996-10-01
AU4582896A (en) 1996-09-19
PT731099E (pt) 2000-11-30
CO4370145A1 (es) 1996-10-07
FI960998A (fi) 1996-09-07
NO313672B1 (no) 2002-11-11
EE9600030A (et) 1996-10-15
CN1313284A (zh) 2001-09-19
PL313070A1 (en) 1996-09-16
HUP9600549A3 (en) 1998-04-28
UA46714C2 (uk) 2002-06-17
ZA961774B (en) 1996-09-17
FI960998A0 (fi) 1996-03-04
EP0731099B1 (de) 2000-06-07
CA2170824A1 (en) 1996-09-07
EP0731099A1 (de) 1996-09-11
HRP960071A2 (en) 1997-12-31
NO960884D0 (no) 1996-03-05
DZ1998A1 (fr) 2002-07-20
PL189206B1 (pl) 2005-07-29
JP3204901B2 (ja) 2001-09-04
HK1013285A1 (en) 1999-08-20
HU222282B1 (hu) 2003-05-28
HUP9600549A2 (en) 1997-07-28
PE43597A1 (es) 1997-12-26
RO116622B1 (ro) 2001-04-30
KR100438633B1 (ko) 2004-07-02
YU13396A (sh) 1999-06-15
CN1176651C (zh) 2004-11-24
ES2147320T3 (es) 2000-09-01
KR960034194A (ko) 1996-10-22
US20030109578A1 (en) 2003-06-12
MA23815A1 (fr) 1996-10-01
SK281817B6 (sk) 2001-08-06
GR3034240T3 (en) 2000-12-29
DE69608721D1 (de) 2000-07-13
IL117349A0 (en) 1996-07-23
IL117349A (en) 2002-09-12
BR9600930A (pt) 1997-12-30
SK29796A3 (en) 1996-10-02
DE69608721T2 (de) 2000-10-05
KR100405579B1 (ko) 2004-03-19

Similar Documents

Publication Publication Date Title
HUP9600549A2 (en) N-(3-benzofuranyl)urea-derivatives
HU9602507D0 (en) Cyclic adhesion-inhibitors
GB9513860D0 (en) Securing devices
DE69604167D1 (en) Vibrator
ZA964973B (en) Mercapto-triazolyl-dioxacycloalkanes
PL324453A1 (en) Sold greasea
ZA968451B (en) Novel sulfonylaminopyrimidines
PL313021A1 (en) Vibrator
AP9600802A0 (en) Libricant
AU705667C (en) N-(3-benzofuranyl)urea-derivatives
GB9518522D0 (en) Bridge device
GB9613352D0 (en) Securing devices
GB9507593D0 (en) Novel pad
GB2302382B (en) Securement device
GB2305869B (en) Amusment devices
AU1105P (en) DALESE Metrosideros excelsus
HU877U (en) Elastic ear-protector
GB9616825D0 (en) Strawcrete (cellucretes)
GB9517968D0 (en) Finger-guard (web-plate)
GB9503664D0 (en) Securing device
GB9512162D0 (en) Cylinder securing device
GB9518345D0 (en) Extension device
GB9509694D0 (en) Supports
GB9517905D0 (en) Improved can
ZA953970B (en) Index-tab arrangement